Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis.

Uchihashi K, Nishijima-Matsunobu A, Matsuyama A, Yamasaki F, Tanabe T, Uemura T, Aragane N, Yakushiji M, Yamamoto M, Aoki S, Toda S.

Hum Pathol. 2013 Nov;44(11):2614-8. doi: 10.1016/j.humpath.2013.04.027. Epub 2013 Aug 16.

PMID:
23954138
2.

RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.

Bahrami A, Weiss SW, Montgomery E, Horvai AE, Jin L, Inwards CY, Folpe AL.

Am J Surg Pathol. 2009 Sep;33(9):1348-54. doi: 10.1097/PAS.0b013e3181aa2311.

PMID:
19609206
3.

Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O'Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW.

Am J Surg Pathol. 2004 Jan;28(1):1-30.

PMID:
14707860
4.

Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).

Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, Ranchere-Vince D, Decouvelaere AV, de la Fouchardiere A, Gill AJ.

Hum Pathol. 2013 Dec;44(12):2711-8. doi: 10.1016/j.humpath.2013.07.016. Epub 2013 Sep 20.

PMID:
24060005
5.

A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors.

Carter JM, Caron BL, Dogan A, Folpe AL.

Am J Surg Pathol. 2015 Jan;39(1):75-83. doi: 10.1097/PAS.0000000000000290.

PMID:
25025444
6.

A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.

Arai R, Onodera T, Terkawi MA, Mitsuhashi T, Kondo E, Iwasaki N.

BMC Musculoskelet Disord. 2017 Feb 13;18(1):79. doi: 10.1186/s12891-017-1446-z.

7.

Phosphaturic mesenchymal tumor, mixed connective tissue type, non-phosphaturic variant: report of a case and review of 32 cases from the Japanese published work.

Honda R, Kawabata Y, Ito S, Kikuchi F.

J Dermatol. 2014 Sep;41(9):845-9. doi: 10.1111/1346-8138.12602. Review.

PMID:
25182295
8.

Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.

Agaimy A, Michal M, Chiosea S, Petersson F, Hadravsky L, Kristiansen G, Horch RE, Schmolders J, Hartmann A, Haller F, Michal M.

Am J Surg Pathol. 2017 Oct;41(10):1371-1380. doi: 10.1097/PAS.0000000000000890.

PMID:
28614212
9.

Phosphaturic mesenchymal tumor of the brain without tumor-induced osteomalacia in an 8-year-old girl: case report.

Ellis MB, Gridley D, Lal S, Nair GR, Feiz-Erfan I.

J Neurosurg Pediatr. 2016 May;17(5):573-7. doi: 10.3171/2015.9.PEDS14617. Epub 2016 Jan 1.

PMID:
26722864
10.

Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.

Puthenveetil PJ, Hattab EM, Peacock M, Horn EM.

J Clin Neurosci. 2013 Aug;20(8):1057-61. doi: 10.1016/j.jocn.2012.09.035. Epub 2013 Apr 23. Review.

PMID:
23618679
11.

Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors.

Tajima S, Fukayama M.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9422-7. eCollection 2015.

12.

Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.

Shiba E, Matsuyama A, Shibuya R, Yabuki K, Harada H, Nakamoto M, Kasai T, Hisaoka M.

Diagn Pathol. 2016 Mar 9;11:26. doi: 10.1186/s13000-016-0477-3.

13.

A case of phosphaturic mesenchymal tumor.

Pallavi R, Ravella PM, Gupta P, Popescu A.

Am J Ther. 2015 Mar-Apr;22(2):e57-61. doi: 10.1097/MJT.0000000000000000.

PMID:
24247100
14.

Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.

Yamada Y, Kinoshita I, Kenichi K, Yamamoto H, Iwasaki T, Otsuka H, Yoshimoto M, Ishihara S, Toda Y, Kuma Y, Setsu N, Koga Y, Honda Y, Inoue T, Yanai H, Yamashita K, Ito I, Takahashi M, Ohga S, Furue M, Nakashima Y, Oda Y.

Histopathology. 2018 Feb;72(3):460-471. doi: 10.1111/his.13377. Epub 2017 Nov 16.

PMID:
28858396
15.

A nonphosphaturic mesenchymal tumor mixed connective tissue variant of the sacrum.

Mavrogenis AF, Sakellariou VI, Soultanis K, Mahera H, Korres DS, Papagelopoulos PJ.

Orthopedics. 2010 Nov 2;33(11):851. doi: 10.3928/01477447-20100924-27.

PMID:
21053876
16.

A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue type.

Graham RP, Hodge JC, Folpe AL, Oliveira AM, Meyer KJ, Jenkins RB, Sim FH, Sukov WR.

Hum Pathol. 2012 Aug;43(8):1334-8. doi: 10.1016/j.humpath.2011.11.020. Epub 2012 Apr 11.

PMID:
22503486
17.

Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report.

Qiu S, Cao LL, Qiu Y, Yan P, Li ZX, Du J, Sun LM, Zhang QF.

Medicine (Baltimore). 2017 Apr;96(17):e6750. doi: 10.1097/MD.0000000000006750.

18.

Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.

Hu FK, Yuan F, Jiang CY, Lv DW, Mao BB, Zhang Q, Yuan ZQ, Wang Y.

Chin J Cancer. 2011 Nov;30(11):794-804. doi: 10.5732/cjc.011.10013. Review.

19.

Pathologic quiz case. A 36-year-old woman with muscle pain and weakness. Phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia.

Reis-Filho JS, Paiva ME, Lopes JM.

Arch Pathol Lab Med. 2002 Oct;126(10):1245-6. No abstract available.

PMID:
12385334
20.

Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.

Mori Y, Ogasawara T, Motoi T, Shimizu Y, Chikazu D, Tamura K, Fukumoto S, Takato T.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Mar;109(3):e57-63. doi: 10.1016/j.tripleo.2009.10.052.

PMID:
20219587

Supplemental Content

Support Center